Unclaimed brand
Discover Ocular Therapeutix's retinal disease treatments. Learn more about AXPAXLI, our potential treatment for wet AMD our sustained-release hydrogel therapy, is redefining outcomes for wet AMD.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#202124
Shark
32, 33, 36
225, 6, 13
11, 8, 0, 86
#021844
Tangaroa
2, 24, 68
220, 94, 14
97, 65, 0, 73
Ocular Therapeutix is a biopharmaceutical company dedicated to improving people's vision and overall quality of life through advanced drug delivery technology. They are committed to revolutionizing treatments for various ocular conditions by developing transformational therapies that provide consistent and sustainable relief. With a strong focus on research and innovation, Ocular Therapeutix offers a range of products and services designed to address different therapeutic areas.
This includes retinal diseases, glaucoma, ocular surface diseases, and ophthalmic surgery. Their proprietary ELUTYX™ technology enables the creation of sustained-release therapies for multiple ocular conditions, eliminating the need for frequent injections or daily eye drops. Ocular Therapeutix is dedicated to safeguarding vision and enhancing lives, and they are constantly exploring new possibilities to provide long-lasting and effective treatments to individuals in need
Company type
Public Company
Year founded
2006
Company size
51-200 employees
Sustained-release hydrogel drug delivery
Intravitreal implants
Wet age-related macular degeneration
Diabetic retinopathy
Retinal disease clinical trials
